Sinew Pharma Inc. (TPEX:6634)
Taiwan · Delayed Price · Currency is TWD 45.65
-0.80 (-1.72%)
Oct 9, 2025, 2:50 PM CST
Sinew Pharma Market Cap
Sinew Pharma has a market cap or net worth of 3.26 billion as of October 10, 2025. Its market cap has decreased by -30.64% in one year.
Market Cap
3.26B
Enterprise Value
2.17B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
45.65
Market Cap Chart
Since June 29, 2017, Sinew Pharma's market cap has increased from 1.90B to 3.26B, an increase of 71.27%. That is a compound annual growth rate of 6.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 3.26B | -4.02% |
| Dec 31, 2024 | 3.39B | -29.30% |
| Dec 29, 2023 | 4.80B | -34.51% |
| Dec 30, 2022 | 7.33B | 29.47% |
| Dec 30, 2021 | 5.66B | 19.05% |
| Dec 31, 2020 | 4.75B | 392.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |